Refine
Has Fulltext
- yes (10)
Is part of the Bibliography
- yes (10)
Document Type
- Journal article (9)
- Doctoral Thesis (1)
Keywords
- adrenocortical carcinoma (4)
- CXCR4 (3)
- C-X-C motif chemokine receptor 4 (2)
- [68Ga]PentixaFor (2)
- chemokine receptor (2)
- endoradiotherapy (2)
- theranostics (2)
- Addisons disease (1)
- Adrenostatika (1)
- CCR7 (1)
- CXCR7 (1)
- CYP11B enzymes (1)
- Cushing’s syndrome (1)
- Etomidat (1)
- Hypercortisolism (1)
- Immunosuppression (1)
- Kaposi sarcoma (1)
- Nebenniere (1)
- PET (1)
- Proliferation (1)
- Steroidbiosynthese (1)
- [177Lu]/[90Y]PentixaTher (1)
- [177Lu]PentixaTher (1)
- [90Y]PentixaTher (1)
- adrenal (1)
- adrenal cortex hormones (1)
- adrenal cortex neoplasms (1)
- adrenal incidentaloma (1)
- adrenal tumors (1)
- adrenostatic compound (1)
- adult patients (1)
- circadian therapy (1)
- etomidate (1)
- glucocorticoid replacement regimens (1)
- hypopituitary patients (1)
- mass spectrometry (1)
- metabolomics (1)
- modified-release hydrocortisone (1)
- multiple myeloma (1)
- premature mortality (1)
- prognosis (1)
- proliferation (1)
- short term (1)
- steroid biosynthesis (1)
- subjective health-status (1)
- therapeutic management (1)
- urine (1)
Institute
- Medizinische Klinik und Poliklinik I (8)
- Klinik und Poliklinik für Nuklearmedizin (4)
- Klinik und Poliklinik für Allgemein-, Viszeral-, Gefäß- und Kinderchirurgie (Chirurgische Klinik I) (2)
- Medizinische Klinik und Poliklinik II (2)
- Pathologisches Institut (2)
- Urologische Klinik und Poliklinik (2)
- Comprehensive Cancer Center Mainfranken (1)
- Medizinische Klinik (bis 2004) (1)
- Theodor-Boveri-Institut für Biowissenschaften (1)
EU-Project number / Contract (GA) number
- 259735 (1)
Background: The clinical signs of adrenal cortical insufficiency (incidence, ca. 25 per million per year; prevalence, ca. 400 per million) are nonspecific, and misdiagnoses are therefore common. Glucocorticoid substitution therapy has been in use for 50 years but is not a wholly adequate treatment. Our understanding of this disease remains incomplete in many ways.
Methods: We selectively searched the Medline database for publications on adrenal cortical insufficiency, with particular attention to studies from the year 2000 onward (search terms: "adrenal insufficiency" or "Addison's disease" or "hypopituitarism"). Results: Hydrocortisone substitution therapy is often given in doses of 10-25 mg/day, timed according to the circadian rhythm. Gastrointestinal and other, febrile infections account for 30-50% of life-threatening adrenocortical crises. Such crises affect 8 of 100 persons with adrenal cortical insufficiency per year and must be treated by the immediate administration of glucocorticoids and fluids. When persons with adrenal cortical insufficiency are acutely ill or are otherwise under unusual stress, they may need additional amounts of hydrocortisone, often in the range of 5-10 mg but occasionally as high as 200 mg. The sustained administration of excessive amounts of steroid can shorten patients' lives by several years. Inappropriate substitution therapy can cause other major medical conditions, such as metabolic syndrome and osteoporosis.
Conclusion: Important measures for the prevention of adrenocortical crises include improved care by treating physicians, education of patients and their families, the provision of emergency identifying documents, and the prescription of glucocorticoid emergency kits.